Physician profile
Sohyun Lim
NPI 1821506775
$2,684.91
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,348 · 2022: $183 · 2023: $132 · 2024: $22.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $651.98 | 2021 | |
| Glaxosmithkline, LLC. | $349.31 | 2021-2023 | Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $284.72 | 2021 | |
| Amgen INC. | $271.51 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $223.50 | 2021 | |
| Abbvie INC. | $222.88 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $159.96 | 2021 | |
| Lilly USA, LLC | $132.51 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.02 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.43 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $59.83 | 2021 | |
| Janssen Pharmaceuticals, INC | $52.43 | 2021 | |
| Ironwood Pharmaceuticals, INC | $44.57 | 2021 | |
| Hologic Sales and Service, LLC | $22.48 | 2024 | Thinprep 2000 Processor, Aptima |
| Ibsa Pharma INC. | $20.92 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $16.96 | 2021 | |
| Dexcom, INC. | $16.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sohyun Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.